A review on the pharmacological effects of hormonal and antidiabetic drugs in the treatment of Polycystic Ovary Syndrome
View/ Open
Date
2019-09Publisher
Brac UniversityAuthor
Biswas, SraboniMetadata
Show full item recordAbstract
Polycystic ovary syndrome is one of the most common heterogenic disorder that affects 5-10%
women during their reproductive age. The purpose of this project is to compare the effects of
hormonal and anti-diabetic drugs associated with polycystic ovary syndrome. The effects of
the anti-diabetic drugs such as metformin, pioglitazone, rosiglitazone, letrozole and hormonal
drugs like ethinyl estradiol, estradiol valerate, cyproterone acetate, medroxyprogesterone
acetate, deinogest, desogestrel, drospirenone on PCOS affected women have been emphasized
in this investigation. In most of the cases, the combination of both hormonal and antidiabetic
drugs have provided better results. This work has been focused on the laboratory assay
techniques, results and discussion provided on these articles. The most advantageous effects of
the available drugs have been emphasized in these work. The researchers and clinicians may
be benefited from this project on the ground of selection of combination drugs for the treatment
of PCOS.